(Q34569922)

3 August 2017

1 reference

title

Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention (English)

1 reference

3 August 2017

1 reference

Timothy A Chan

1

1 reference

3 August 2017

1 March 2002

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

3

1 reference

3 August 2017

166-174

1 reference

3 August 2017

3

1 reference

Recent advances: oncology

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Effects of Long-term Sulindac Therapy on Colonic Polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Rectal cancer in FAP patient after sulindac.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing ad

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Identification of FAP locus genes from chromosome 5q21

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac suppresses tumorigenesis in the Min mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Aspirin prevents tumors in a murine model of familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac inhibits the rate of growth and appearance of colon tumors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Combinatorial chemoprevention of intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Introduction: mechanism of action of NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Elevated cyclooxygenase-2 levels in Min mouse adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Functions of ceramide in coordinating cellular responses to stress

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Intracellular unesterified arachidonic acid signals apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Potential use of lipoxygenase inhibitors for cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Enhanced apoptosis and transforming growth factor-beta1 expression in colorectal adenomas and carcinomas after Sulindac therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900680-0

7 January 2021

10.1016/S1470-2045(02)00680-0

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11902503